Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 14.5313.9611.0922.7930.42

What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS is 14.53 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202514.53
Mar202413.96
Mar202311.09
Mar202222.79
Mar202130.42

How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 14.53
4.08
Mar2024 13.96
25.88
Mar2023 11.09
-51.34
Mar2022 22.79
-25.08
Mar2021 30.42 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹374.3 Cr -10.7% 14.5% 121.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,428.0 Cr 1.5% -3% 6.7% Stock Analytics
DIVIS LABORATORIES ₹175,426.0 Cr -2.2% -4.5% 0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,603.0 Cr 0.8% 2.3% 43.9% Stock Analytics
CIPLA ₹111,604.0 Cr 0.4% -4% -7.8% Stock Analytics
DR REDDYS LABORATORIES ₹106,775.0 Cr 0.8% -1.8% -3.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-10.7%

14.5%

121.7%

SENSEX

3.7%

2.2%

-7.2%


You may also like the below Video Courses